Key residues influencing binding affinities of 2019-nCoV with ACE2 in different species.

Senbiao Fang1 Ruoqian Zheng1 Chuqi Lei2 Jianxin Wang3 Ruiqing Zheng3 Min Li3
Affiliations 3 institutions
  1. Xiangtan University, Xiangtan, China.
  2. Central South University, China.
  3. Central South University, Changsha, China.
Active Last checked 2026-10-05 03:30:31 Source: NCBI PubMed

Abstract

The Novel Coronavirus Disease 2019 (COVID-19) has become an international public health emergency, which poses the most serious threat to the human health around the world. Accumulating evidences have shown that the new coronavirus could not only infect human beings, but also can infect other species which might result in the cross-species infections. In this research, 1056 ACE2 protein sequences are collected from the NCBI database, and 173 species with >60% sequence identity compared with that of human beings are selected for further analysis. We find 14 polar residues forming the binding interface of ACE2/2019-nCoV-Spike complex play an important role in maintaining protein-protein stability. Among them, 8 polar residues at the same positions with that of human ACE2 are highly conserved, which ensure its basic binding affinity with the novel coronavirus. 5 of other 6 unconserved polar residues (positions at human ACE2: Q24, D30, K31, H34 and E35) are proved to have an effect on the binding patterns among species. We select 21 species keeping close contacts with human beings, construct their ACE2 three-dimensional structures by Homology Modeling method and calculate the binding free energies of their ACE2/2019-nCoV-Spike complexes. We find the ACE2 from all the 21 species possess the capabilities to bind with the novel coronavirus. Compared with the human beings, 8 species (cow, deer, cynomys, chimpanzee, monkey, sheep, dolphin and whale) present almost the same binding abilities, and 3 species (bat, pig and dog) show significant improvements in binding affinities. We hope this research could provide significant help for the future epidemic detection, drug and vaccine development and even the global eco-system protections.

Angiotensin-Converting Enzyme 2 178 Animals 1981 Humans 1455 Protein Binding 194 SARS-CoV-2 456 Species Specificity 84 Spike Glycoprotein, Coronavirus 276 spike protein, SARS-CoV-2 158

Evidence records

0 total

No structured evidence records are linked to this article.